Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain

• Status: Completed
• Trial end date: 2001-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Javelin Pharmaceuticals
• Treatments: Ketamine

Criteria

Inclusion Criteria:

• Healthy patients at least 16 years of age requiring two or more third molar extractions

Exclusion Criteria:

• Less than 16 years old

• Other exclusion criteria may apply